UPDATE 1-Hospira's profit beats estimates on higher pricing, sales

Nov 6 (Reuters) - Drugmaker Hospira Inc reported a quarterly profit that handily beat analysts' estimates as the company raised prices and sold more of its injectables.

from Reuters: Hot Stocks http://ift.tt/1uABjw2